AIMEI Shares Skyrocket 51% Amid $1.6B United Hydrogen SPAC Deal

Introduction to AIMEI Health Technology Co. Ltd.

AIMEI Health Technology Co. Ltd. (NASDAQ: AFJK), a Cayman Islands–incorporated special purpose acquisition company (SPAC), completed a $70 million initial public offering (IPO) in 2024. Trading under the ticker AFJK, the company focuses on structuring business combinations with targets in the health‐technology and clean-energy sectors. Its Korean name is 아이메이 헬스 테크놀로지.

Corporate Structure and Experience

Public disclosures do not specify total headcount; however, board composition and advisory relationships suggest a management team with industry experience. An independent director who spoke at the NASDAQ IPO ceremony brings corporate governance experience aided by connections with ARC Group, Spartan Capital, and legal advisors at Loeb & Loeb. These partnerships indicate access to financial, legal, and industry expertise essential for post-listing operations.

Hydrogen Energy by Federico Beccari

Developments and News

• June 20, 2024: AIMEI entered into a definitive business combination agreement with United Hydrogen Group Inc., valuing the combined entity on a pro forma basis at approximately $1.6 billion. Upon closing, United Hydrogen’s shareholders will roll 100 percent of their equity into the new public holding company.
• December 2, 2025, and December 8, 2025: The company filed two Form 8-K reports (CIK 0001979005) covering material agreements, governance changes, and other corporate matters.
• November 18, 2025: A 10-Q filing provided quarterly updates, although detailed financial metrics were not publicly disclosed.
• December 9, 2025: Shares closed at $12.09—a gain of 51.13 percent—on a volume of 121,873 shares traded.

Financial and Strategic Analysis

On December 9, 2025, AIMEI’s share price reached $12.09, reflecting increased market activity following key SPAC milestones. According to CNBC, the company’s market capitalization was approximately $63 million, with 7.87 million shares outstanding and a 52-week trading range of $7.60 to $26.20.

Strategically, the pending combination with United Hydrogen positions AIMEI to leverage hydrogen energy solutions—from production and storage to material-handling applications—under a publicly traded holding company. Management has noted that a flexible business model, digital monitoring systems, and partnerships with industry leaders serve as competitive differentiators within the green-energy sector.

Market Position and Industry Context

AIMEI operates at the intersection of healthcare technology finance and green-energy investment. Its SPAC structure has enabled access to public markets for a company specializing in clean-hydrogen solutions—a sector that may benefit from global decarbonization policies and corporate demand for zero-emission options. The combined entity is expected to offer end-to-end hydrogen services in China and potentially other regions, aligning with government incentives and corporate sustainability targets.

TL;DR

On December 9, 2025, AIMEI’s stock increased by 51.13 percent to $12.09 following interest in its $1.6 billion pro forma business combination with United Hydrogen Group Inc. The deal, announced on June 20, 2024, will establish a Nasdaq-listed hydrogen-energy holding company. The completion of the transaction and subsequent share conversion are anticipated to be significant steps for realizing long-term value.